# ArriVent BioPharma, Inc.: Form SCHEDULE 13D/A, filed Oct 8, 2026

- Company: [ArriVent BioPharma, Inc.](/companies/avbp.md) (CIK 1868279)
- Form: SCHEDULE 13D/A
- Filed: 2026-10-08
- Accepted by EDGAR: Oct 8, 2026, 18:39 ET
- Period: not reported
- Accession: 0000947871-26-000931
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1868279/000094787126000931/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1868279/000094787126000931/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1868279/000094787126000931/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Oct 8, 2026.
Source: SEC EDGAR, the filing index for accession 0000947871-26-000931. Last ingested by Listed: Nov 10, 2026, 02:46 ET. No prices; not investment advice.
